EE307 Cost-Utility Analysis of Pegunigalsidase Alfa Compared to Agalsidase Alfa and Agalsidase Beta for the Treatment of Adult Patients With Fabry Disease in Greece
Abstract
Authors
Katerina Vellopoulou Katerina Lioliou Figaleia Karathanou Eirini Kiorpelidi Ilias Pyrnokokis Khashayar Azimpour Irene Koulinska Evangelia Dounousi Georgios Tsivgoulis Georgia Kourlaba